Could common diabetes pills protect transplant Patients' hearts?

This study tested if two common diabetes medications, metformin and empagliflozin, could safely improve metabolism and reduce heart disease risk in people who have received a kidney transplant. It involved 105 recent transplant recipients, with or without diabetes, who were randomly assigned to take one of the drugs or neither for a year. The main goal was to see if the drugs safely changed body fat distribution, a key marker for future heart problems.